161 related articles for article (PubMed ID: 33422975)
21. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.
Lu Y; García Rodríguez LA; Malgerud L; González-Pérez A; Martín-Pérez M; Lagergren J; Bexelius TS
Br J Cancer; 2015 Dec; 113(11):1607-14. PubMed ID: 26575601
[TBL] [Abstract][Full Text] [Related]
22. Use of statins and the risk of acute pancreatitis: a population-based case-control study.
Kuoppala J; Pulkkinen J; Kastarinen H; Kiviniemi V; Jyrkkä J; Enlund H; Happonen P; Paajanen H
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1085-92. PubMed ID: 26300102
[TBL] [Abstract][Full Text] [Related]
23. Pancreatitis and pancreatic cancer: a population-based study.
Ekbom A; McLaughlin JK; Karlsson BM; Nyrén O; Gridley G; Adami HO; Fraumeni JF
J Natl Cancer Inst; 1994 Apr; 86(8):625-7. PubMed ID: 8145277
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced pancreatitis: an update.
Trivedi CD; Pitchumoni CS
J Clin Gastroenterol; 2005 Sep; 39(8):709-16. PubMed ID: 16082282
[TBL] [Abstract][Full Text] [Related]
25. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Elashoff M; Matveyenko AV; Gier B; Elashoff R; Butler PC
Gastroenterology; 2011 Jul; 141(1):150-6. PubMed ID: 21334333
[TBL] [Abstract][Full Text] [Related]
26. Polypharmacy and risk of acute pancreatitis.
Razavi D; Lindblad M; Bexelius T; Oskarsson V; Sadr-Azodi O; Ljung R
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1337-1341. PubMed ID: 27651204
[TBL] [Abstract][Full Text] [Related]
27. Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study.
Chou HC; Chen WW; Hsiao FY
Drug Saf; 2014 Jul; 37(7):521-8. PubMed ID: 24859164
[TBL] [Abstract][Full Text] [Related]
28. Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.
Soranna D; Bosetti C; Casula M; Tragni E; Catapano AL; Vecchia CL; Merlino L; Corrao G
Diabetes Res Clin Pract; 2015 May; 108(2):243-9. PubMed ID: 25748827
[TBL] [Abstract][Full Text] [Related]
29. Statin use and the risk of pancreatic cancer: a population-based case-control study.
Chiu HF; Chang CC; Ho SC; Wu TN; Yang CY
Pancreas; 2011 Jul; 40(5):669-72. PubMed ID: 21654539
[TBL] [Abstract][Full Text] [Related]
30. Quantifying the Risk of Drug-Induced Pancreatitis With Angiotensin-Converting Enzyme Inhibitors and Statins Using a Large Electronic Medical Record Database.
Twohig PA; de-Madaria E; Thakkar S; Dulai P; Gardner TB; Kochhar G; Sandhu DS
Pancreas; 2021 Sep; 50(8):1212-1217. PubMed ID: 34714286
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases.
Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Ockenga J; Kreutz R; Garbe E
Aliment Pharmacol Ther; 2013 Oct; 38(7):825-34. PubMed ID: 23957710
[TBL] [Abstract][Full Text] [Related]
32. Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study.
Kirkegård J; Lund JL; Mortensen FV; Cronin-Fenton D
Int J Cancer; 2020 Feb; 146(3):610-616. PubMed ID: 30861115
[TBL] [Abstract][Full Text] [Related]
33. A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients.
Tomlin AM; Reith DM; Woods DJ; Lloyd HS; Smith A; Fountain JS; Tilyard MW
Drug Saf; 2017 Dec; 40(12):1259-1277. PubMed ID: 28766108
[TBL] [Abstract][Full Text] [Related]
34. Development of a Web-Based System for Exploring Cancer Risk With Long-term Use of Drugs: Logistic Regression Approach.
Yang HC; Islam MM; Nguyen PAA; Wang CH; Poly TN; Huang CW; Li YJ
JMIR Public Health Surveill; 2021 Feb; 7(2):e21401. PubMed ID: 33587043
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
[TBL] [Abstract][Full Text] [Related]
36. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
37. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?
Boursi B; Mamtani R; Haynes K; Yang YX
Eur J Cancer; 2015 Nov; 51(17):2655-64. PubMed ID: 26338196
[TBL] [Abstract][Full Text] [Related]
38. Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case-Control Study.
Lai SW; Lin CL; Liao KF
Clin Drug Investig; 2015 Oct; 35(10):653-7. PubMed ID: 26359031
[TBL] [Abstract][Full Text] [Related]
39. Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population.
Romley JA; Goldman DP; Solomon M; McFadden D; Peters AL
Diabetes Technol Ther; 2012 Oct; 14(10):904-11. PubMed ID: 22845701
[TBL] [Abstract][Full Text] [Related]
40. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
